Page 825 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

INDEX INDEX 781

Mediastinal lymphadenopathy, 676 Melasma (chloasma), 476 Menopause, 636 rate-determining enzymes, 73
Mediastinal pathology, 672 MELAS syndrome, 59 hormone replacement therapy, 657 summary of pathways, 74
Mediastinitis, 672 Melatonin primary ovarian insufficiency, 645 TCA cycle, 77
in pulmonary anthrax, 137 circadian rhythms and, 497 Turner syndrome, 638 tyrosine catabolism, 83
Medical abortion Melatonin receptor agonist Menorrhagia, 633 urea cycle, 82
ethical situations, 268 Ramelteon as, 547 anemia with, 418 Metacarpal neck fracture, 459
methotrexate for, 440 Melena Menstrual cycle Metacarpophalangeal (MCP) joints,
Medical errors Meckel diverticulum, 384, 618 estrogens for, 656 451
analysis of, 274 polyarteritis nodosa, 314 heavy bleeding (AUB/HMB), 633 Metachromatic granules
assessment of, 268 Meloxicam, 486 phases of, 632 Corynebacterium diphtheriae
types of, 274 Memantine, 549 Meperidine, 551 diagnosis, 139
Medical insurance plans, 271 Membrane attack complex (MAC), Mepivacaine, 550 Metachromatic leukodystrophy, 88,
Medical power of attorney, 266 104 Mercury poisoning, 248 524
Medicare/Medicaid, 272 complement and, 106 Merkel discs, 494 Metalloproteinases, 216
Medication errors, 274 Membranoproliferative Merlin protein, 224 Metal storage diseases, 210
Medication noncompliance, 268 glomerulonephritis MERS (Middle East respiratory Metanephros, 578
Medium-chain acyl-CoA (MPGN), 596 syndrome), 167 Metaphase, 46
dehydrogenase deficiency, hepatitis B and C, 173 Mesalamine, 382 Metaplasia, 206
89 Membranous glomerular disorders, Mesangial cells benign breast disease, 649
Medium-vessel vasculitis 594 juxtaglomerular apparatus, 589 esophagus, 378
presentation and pathology, 314 hepatitis B and C, 173 Mesencephalon, 490 intestinal, 379
Medroxyprogesterone, 657 Membranous interventricular Mesenchymal tumors specialized intestinal, 378
Medulla (brain) septum, 281 nomenclature of, 220 Metastases
adrenal cortex and, 327 Membranous nephropathy, 597 Mesenteric arteries, 363 common, 223
cranial nerves and nuclei, 505 primary autoantibody, 115 Mesenteric ischemia, 386 Metastasis, 219, 223
development of, 490 Membranous ossification, 458 Mesocortical pathway, 499 gastric cancer, 379
spinal tracts and, 509 Membranous urethra injury, 627 Mesoderm, 490 heart tumors from, 316
strokes in, 514–515 Membranous ventricular septum, 281 branchial arches derivation, 619 liver cancer, 392
Medulla (lymph nodes) Memory derivatives of, 613 lung, cancer, 684
lymph nodes, 96 neural structures and, 499 Mesolimbic pathway, 499 Metastatic calcification, 211
thymus, 102 Memory loss Mesometrium, 625 Metastatic melanoma
Medullary breast carcinomas, 650 anti-NMDA receptor encephalitis, Mesonephric (Wolffian) duct, 622 vemurafenib for, 444
Medullary cystic kidney disease, 228 Mesonephros, 578 Metatarsophalangeal (MTP) joints
604 lead poisoning, 425 Mesosalpinx, 625 gout, 467
Medullary thyroid carcinomas, 343, Wernicke-Korsakoff syndrome, 511 Mesothelioma, 678 Metencephalon, 490
351 MEN1 gene, 224, 352 carcinogens causing, 225 Metformin, 353
Medulloblastoma, 350, 528 Ménétrier disease, 379 Psammoma bodies in, 227 diarrhea with, 249
“Medusa head” appearance, 137 Ménière disease, 534 Mesovarium, 625 Methacholine, 240
Mefloquine, 157 Menin, 224 Mestranol, 656 Methadone, 551
Megacolon Meninges, 496 Meta-analysis, 263, 264 heroin addiction, 576
Chagas disease, 158 Meningiomas, 526 Metabolic acidosis, 592
in Hirschsprung disease, 384 Psammoma bodies in, 227 adrenal insufficiency, 349 intoxication and withdrawal, 570
Megakaryocytes in essential Meningitis renal failure, 603 Methamphetamine, 572
thrombocythemia, 433 ceftriaxone, 189 symptoms of, 593 Methanol toxicity, 248
Megaloblastic anemia, 420 chloramphenicol, 192 Metabolic alkalosis, 592 Methemoglobin, 666
cytarabine, 440 coccidioidomycosis, 151 hyperaldosteronism, 349 toxicity treatment, 248
Diphyllobothrium latum, 160 common causes, 180 in hypertrophic pyloric stenosis, Methemoglobinemia, 666
drug reaction and, 250 Cryptococcus neoformans, 153 359 local anesthetics and, 550
orotic aciduria, 420 CSF findings in, 180 loop diuretics, 608 Methicillin, 249
trimethoprim, 194 fluconazole, 199 nephron transport, 586 Methimazole, 354
tropical sprue, 381 flucytosine, 199 thiazides, 609 agranulocytosis, 250
vitamin B deficiency, 68 Haemophilus influenzae, 142 Metabolic disorders aplastic anemia, 250
9
vitamin B deficiency, 69 headaches with, 518 fructose, 80 teratogenicity, 614
12
Megestrol, 657 HIV-positive adults, 177 galactose, 80 Methionine
Meglitinides, 353 Listeria monocytogenes, 139 glycogen storage, 87 classification of, 81
Meissner corpuscles, 494 meningococci, 142 lysosomal storage diseases, 88–89 start codons, 44
Meissner plexus, 384 mumps, 170 Metabolic fuel use, 91 sulfonamides and, 194
Melanocytes in neonates, 182 Metabolic syndrome Methotrexate, 440
tumor nomenclature in, 220 rifamycin prophylaxis, 196 with antipsychotic drugs, 573 folate deficiency, 420
Melanocyte-stimulating hormone Streptococcus pneumoniae, 136 non-alcoholic fatty liver disease hydatidiform moles, 642
(MSH) Streptococcus agalactiae, 137 and, 391 megaloblastic anemia, 250
function of, 328 unvaccinated children, 186 Metabolism, 72–94 pulmonary fibrosis, 251
secretion of, 327 Meningocele, 491 amino acid derivatives, 83 pyrimidine synthesis and, 36
signaling pathways of, 337 Meningococcal prophylaxis, 198 amino acids, 81 rheumatoid arthritis, 466
Melanocytic nevus, 477 Meningococcal vaccine, 127 apolipoproteins, 93 targets of, 438
Melanoma, 484 Meningococcemia cellular sites of, 72 teratogenicity, 614
common metastases, 223 endotoxins, 131 disorders of, 81, 84–85 vitamin B deficiency, 68
9
immunohistochemical stain for, Meningococci, 131, 142 drugs, 232 as weak acid, 233
227 Meningoencephalitis dyslipidemias, 94 Methoxyflurane, 550
nomenclature for, 220 HSV-2, 182 ethanol, 72, 232 Methylation
oncogene, 224 Naegleria fowleri, 156 fatty acid, 89 histones, 45
origin of, 220 West Nile virus, 167 fuel use, 91 Methyldopa
recombinant cytokines for Meningomyelocele, 491 gluconeogenesis, 78 Coombs-positive hemolytic
metastatic, 121 Menkes disease glycogen and, 86 anemia, 250
tumor suppressor gene, 224 mechanism and symptoms, 51 lipoprotein functions, 93, 94 hypertension in pregnancy, 316
Melarsoprol, 156, 200 protein (ATP7A), 51 pyruvate, 77 Methylene blue, 248

FAS1_2019_21_Index_749-806.indd 781 11/21/19 12:27 PM